Cutaneous manifestations often provide critical insights into underlying systemic diseases, serving as visible indicators that may precede, accompany, or follow internal organ involvement. The skin, being the body’s largest and most accessible organ, reflects a wide range of pathophysiologic processes occurring within the body. This connection between dermatologic signs and systemic conditions is fundamental in clinical practice, enabling early diagnosis, guiding investigations, and influencing therapeutic decisions. Awareness of these skin changes is therefore paramount for clinicians beyond dermatology, including internists, rheumatologists, oncologists, and primary care practitioners. The diagnostic evaluation of cutaneous manifestations associated with systemic disease necessitates a thorough and systematic approach. It begins with detailed patient history and comprehensive physical examination, emphasizing the chronology, distribution, and evolution of skin lesions alongside systemic symptoms. Attention to family and occupational histories, medication exposures, and travel background enriches the clinical context. Laboratory investigations tailored to suspected systemic conditions enhance diagnostic accuracy and may include autoantibody panels, metabolic profiles, infectious disease markers, and imaging studies for internal organ assessment. Managing cutaneous manifestations of systemic diseases involves addressing both the skin lesions and the underlying systemic pathology. Targeted pharmacologic therapies, such as immunosuppressants in autoimmune diseases or antimicrobials in infections, aim to modify disease activity. Concurrent skin care, including emollients, topical corticosteroids, and avoidance of irritants, supports barrier restoration and symptom relief. Psychological and social support are integral, given the often visible and chronic nature of these skin changes impacting patients’ quality of life.